Is the FDA Protecting Patients from the Dangers of Silicone Breast Implants?: Hearing Before the Human Resources and Intergovernmantal Relations Subcommittee of the Committee on Government Operations, House of Representatives, One Hundred First Congress, Second Session, December 18, 1990U.S. Government Printing Office, 1991 - 426 pages |
Autres éditions - Tout afficher
Expressions et termes fréquents
ASPRS associated augmentation autoclaving autoimmune disease breast augmentation breast cancer breast prostheses breast reconstruction brochure cancer risk capsular contracture capsule capsulotomy carcinogenic carcinoma CDRH clinical collagen complications cosmetic degradation detection documents Dow Corning FDA's fill tube fluid foreign body gel-filled breast prostheses human adjuvant disease hydrolysis injections inserted Kossovsky lips mammary implants mammary prosthesis manufacturers mastectomy materials medical devices occur package pain panel patients physicians Plastic and Reconstructive plastic surgeons polyester polyester polyurethane foam polymer polyurethane polyurethane covered polyurethane foam covering potential problems prosthesis PU foam reaction recommended registry release removed reported response Risk Assessment Committee rupture saline scar scientific scleroderma sensitization shell SILASTIC silica silicone breast implants silicone gel silicone gel-filled breast silicone implants silicone mammary skin sterile Subcommittee surgery surgical procedure SURGITEK Ted Weiss tissue expander tumors valve WEISS women
Fréquemment cités
Page 49 - DEPARTMENT OF HEALTH AND HUMAN SERVICES BEFORE THE SUBCOMMITTEE ON HUMAN RESOURCES AND INTERGOVERNMENTAL RELATIONS COMMITTEE ON GOVERNMENT OPERATIONS US HOUSE OF REPRESENTATIVES JUNE 4, 1992 FOR RELEASE ONLY UPON DELIVERY Good Morning Mr.
Page 104 - FDA operating costs would include: system review; system operation, maintenance, and equipment upgrades; contract monitoring, data evaluation, and data validation; programming, data analysis, and coordination with other CDRH databases; training and education of contract personnel, manufacturers, and patients; interagency agreements with the Internal Revenue Service (IRS), the Social Security Administration (SSA), and the NCHS's National Death Index for address searches, and; Center staff work and...
Page 119 - We have your prepared statement and that will be entered into the record in its entirety. We would appreciate it if you could summarize your statement in about 6 minutes so that we can ask you some questions.
Page 97 - Admiral, do you swear or affirm to tell the truth, the whole truth, and nothing but the truth?
Page 246 - Caution: Federal law restricts this device to sale by or on the order of a " the blank to be filled with the word "physician...
Page 177 - Checks" that describes the use of these different methods is available upon request from the Dockets Management Branch (HFA-305), Food and Drug Administration, Room 4-62, 5600 Fishers Lane, Rockville, MD 20857.